| Literature DB >> 34070179 |
Kanchan Bhardwaj1, Ana Sanches Silva2,3, Maria Atanassova4, Rohit Sharma5, Eugenie Nepovimova6, Kamil Musilek6, Ruchi Sharma7, Mousa A Alghuthaymi8, Daljeet Singh Dhanjal9, Marcello Nicoletti10, Bechan Sharma11, Navneet Kumar Upadhyay12, Natália Cruz-Martins13,14,15, Prerna Bhardwaj1, Kamil Kuča6.
Abstract
Conifers have long been recognized for their therapeutic potential in different disorders. Alkaloids, terpenes and polyphenols are the most abundant naturally occurring phytochemicals in these plants. Here, we provide an overview of the phytochemistry and related commercial products obtained from conifers. The pharmacological actions of different phytochemicals present in conifers against bacterial and fungal infections, cancer, diabetes and cardiovascular diseases are also reviewed. Data obtained from experimental and clinical studies performed to date clearly underline that such compounds exert promising antioxidant effects, being able to inhibit cell damage, cancer growth, inflammation and the onset of neurodegenerative diseases. Therefore, an attempt has been made with the intent to highlight the importance of conifer-derived extracts for pharmacological purposes, with the support of relevant in vitro and in vivo experimental data. In short, this review comprehends the information published to date related to conifers' phytochemicals and illustrates their potential role as drugs.Entities:
Keywords: anti-inflammatory; antibacterial; anticancer; conifers; neurodegenerative; oxidative stress; phytoconstituent
Year: 2021 PMID: 34070179 PMCID: PMC8158490 DOI: 10.3390/molecules26103005
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Global distribution of all conifers [11].
Phytochemical constituents present in conifers.
| Subclasss | Main Examples of Each Class | Conifer spp. | References |
|---|---|---|---|
|
| |||
| Monoterpenes | β-myrcene, α-pinene, limonene, α-terpinene, thujone, camphene, β-pinene, thujole, Δ-3-carene, phellandrene |
| [ |
| Sesquiterpenes | Laurenobiolide, farnesene, inulicin, vernodalin, 3 |
| [ |
| Diterpenes | Paclitaxel, 10-deacetylbaccatin III, tasumatrol B, taxodal, sandaracopimaric acid, taxodione, xanthoperol, andrographolide, gibberellin A8, 7α-hydroxysandaracopimaric acid, gibberellin A12, gibberellin A12 aldehyde, gibberellin A15, 14α-hydroxyisopimaric acid, 12-hydroxydehydroabietic acid, gibberellin A19, gibberellin A9, carnosol, lathyrol, |
| [ |
|
| |||
| Alkaloids | Vellosimine, 1,6-dehydropinidine, cis-pinidine, 1,6-dehydropinidinone, epipinidinone, cis-pinidinol, trans-pinidine, euphococcinine, α-pipecoline 1, (−)-pinidine |
| [ |
| Lignans | Lariciıesinol, taxiresinol, 3’-demethylisolariciresino1-9’-hydroxyisopropylethe, isolariciresinol, deoxypodophyllotoxin, (−)-secoisolariciresinol, 3, 3-demethylisolariciresinol, isotaxiresinol 2, α-conidendrin, (+)-pinoresinol, (−)-matairesinol, arctiin, dibenzylbutyrolactol, (−)-wikstromol, (−)-traxillagenin, (−)-arctigenin, traxillaside, 4′-deme-thyltraxillagenin, [(2 |
| [ |
|
| |||
| Flavanonols | Taxifolin, cedeodarin |
| [ |
| Flavones | Pilosanol B, luteolin, apigenin, apigenin 6-C-b-glucopyranoside |
| [ |
| Biflavones | Bilobetin, cupressuflavone II-7- |
| [ |
| Flavonols | Quercetin, dihydroquercetin, rutin, kaempferol, dihydrokaempferol |
| [ |
| Flavan-3-ols | Monomers: (−)-epicatechin, (−)-epicatechin-3-gallate, (+)-catechin, sennidin A, (−)-epigallocatechin, |
| [ |
| Polymers: Procyanidin B1, B2, procyanidin A2, |
| [ | |
|
| |||
| Benzoic acids | p-hydroxybenzoic acid, 2,5-dihydroxobenzoic acid, gallic acid, 4-hydroxybenzoic acid, protocatechuic acid, ellagic acid |
| [ |
| Hydroxycinnamic acid | Caffeic acid, t-cinnamic Acid, p-coumaric acid, vanillic acid, ferulic acid, salicylic acid, sinapic acid, syringic acid, chlorogenic acid, 5-caffeoylquinic acid, caffeic acid 4- |
| [ |
| Stilbenes | trans-resveratrol, resveratrol, trans-pinosylvin, cis-stilbenes, pinosylvin, dihydro-monomethyl, trans-stilbenes, trans-piceatannol, trans-piceid, trans-isorhapontin, trans-isorhapontigenin, phenanthrenes, astringin, trans-astringin |
| [ |
Figure 2Structures of phytochemical compounds present in different conifer spp.
Figure 3Action mechanism of conifers’ phytochemical compounds in oxidative stress, apoptosis, and neurodegenerative diseases. The phytochemicals’ multi-target effects in the brain include mitochondrial protection, anti-aggregation, anti-oxidant, anti-apoptotic and anti-inflammatory activity.
Antioxidant capacity of extracts obtained from different conifer spp.
| Conifer spp. | Part Used | Compounds | Nature of Extract | Radical Scavenging Assay | Dose/Concentration | Main Effects | References |
|---|---|---|---|---|---|---|---|
|
| Leaves | Phenolic compounds | Methanol, chloroform, petroleum ether | DPPH | 1000 μg/mL | Methanol extract shows the best antioxidant activity with 63% inhibition, higher than the other two compounds | [ |
|
| Needle | Flavanoids | Methanol | DPPH | 50–72.5 μg/mL | Methanol/water extract shows antioxidant activity | [ |
|
| Heart wood | Tannins, flavonoids, and phenolic compounds | Water/alcohol | DPPH, superoxide radical-scavenging activity, ABTS | DPPH-IC50 (μg/mL): 61.89 (water extract), | DPPH radical-scavenging activity and the reducing power of | [ |
|
| All parts | Phenolic compounds | Methanol | ORAC, | 4.09–7.64 TE/mg | The methanol extracts from each part of | [ |
|
| Berry | Flavanoids (quercetin rutin, | Alcohol/Water | DPPH | EC50 1.42 mg/mL against standard Ascorbic acidEC50 value of 0.365 mg/mL | The antioxidant activity was confirmed as 81.63 ± 0.38% by the DPPH assay. | [ |
|
| Bark | Phenolic compounds | Ethanol/Water | ORAC | IC50 0.878 μg/mL. | Bark extract of LL shows significant antioxidant activity | [ |
| Metasequoia glyptostroboides | Cone | Terpenoid | Ethyl acetate | DPPH, NO, superoxide, and H2O2 | 5–250 μg /mL | Sugiol derived from cone extract show good antioxidant activity—78.38, 72.42, 74.45 and 85.04%, respectively. | [ |
|
| Bark | Atilbenoids | Ethanol/Water | DPPH | 49.74 μg/mL | UVA-induced modification of the stilbene-rich inner bark extracts increased the antioxidant activity as UVA irradiation decreased the capacity of the extracts to prevent lipid oxidation in the liposome system method | [ |
|
| Leaves | Phenolic compounds | Methanol | DPPH | IC50 (μg/mL)- | Results of the DPPH radical scavenging activity and FRAP study determine that methanol extracts of leaf displayed the highest antiradical efficiency | [ |
| 228 | |||||||
| FRAP | 494 | ||||||
| Reducing Power assay | 978 | ||||||
|
| Bark | Phenolic compounds | Ethanol | DPPH | IC50 value μg/mL | [ | |
| 102.8 | |||||||
| H2O2 | 81.83 | ||||||
| NO2 | 109.2 | ||||||
|
| Bark | Phenolic compounds | Ethanol/Water | IC50 (μg/mL). Ethanol and the water | Ethanol and water extract of bark exhibited significant free radical neutralization capacities, at conc. 0.5–8 μg/mL | [ | |
| DPPH | 3.28, 3.26 | ||||||
| ABTS | 3.1, 3.59 | ||||||
|
| Bark | Phenolic compounds | Ethanol/Water | PB (50%) and (90%) IC50 value μg/mL | PP bark extracts formed from PB 50% (50% ethanol) have maximum (DPPH, ABTS) radical scavenging activity while FRAP shows activity with (PB 90%) | [ | |
| DPPH | 49.74 | ||||||
| ABTS | 59.41 | ||||||
| FRAP | 101.3 | ||||||
|
| Bark | Phenolic compounds | Ethanol | IC50 value μg/mL | Pine extract shows significant antioxidant activity | [ | |
| DPPH | 97.54 | ||||||
| H2O2 | 86.90 | ||||||
| NO2 | 111.38 | ||||||
|
| Bark | Phenolic compounds | Ethanol | IC50 (μg/mL) | Pine extract shows significant radical scavenging activity | [ | |
| DPPH | 111.40 | ||||||
| H2O2 | 84.18 | ||||||
| NO2 | 98.5 | ||||||
|
| Leaves | Flavonoids, phenols | Methanol | DPPH, FRAP | 20–100 μg/mL | Crude extract shows significant antioxidant activity | [ |
|
| Non-woody | Polyphenol, flavonoids | Mother tincture (MT) | DPPH, ORAC, NO | 25 or 50 mg/kg | [ | |
|
| Leaves and | Flavonoids, phenols | Methanol | DPPH | IC50 (μg/mL) 105.41, 518.51 leaves and cones resp. | Acetone and ethyl acetate extract of leaves show good scavenging activity | [ |
| Water | DPPH | 533.66, >1000 leaves and cones resp. | |||||
| Acetone | DPPH | 25.24, 81.43 leaves and cones resp. | |||||
| Ethyl acetate | DPPH | 29.84, 180.26 leaves and cones resp. | |||||
| Petroleum ether | DPPH | 438.92, > 1000 leaves and cones resp. | |||||
|
| Leaves | Terpenoids, flavonoids | IC50 values (μg/mL) | The maximum DPPH activity was observed in methanol extract (91.25%), followed by water (87.64%), ethanol (85.23%), and ethyl acetate (83.27%) at the highest concentration (700μg/ml) | [ | ||
| Methanol | Superoxide radical | 170.30 | |||||
| DPPH | 212.00 | ||||||
| LPO | 126.09 | ||||||
| Hydroxyl radical | 82.34 | ||||||
| Ethyl acetate | Superoxide radical | 297.55 | |||||
| DPPH | 301.80 | ||||||
| LPO | 151.96 | ||||||
| Hydroxyl radical | 199.05 | ||||||
| Water | Superoxide radical | 257.00 | |||||
| DPPH | 258.29 | ||||||
| Hydroxyl radical | 175.33 | ||||||
|
| Leaf, stem | Polyphenols, flavanoids, terpenoids | Methanol | DPPH | IC50 value (μg/mL.) | DPPH and FRAP activity of TW leaves and stem extract have high antioxidant activities. | [ |
PB-Pine bark; TW-Taxus wallichiana.
Anti-inflammatory capacity of different conifers spp.
| Conifer spp. | Part Used | Nature of Extract | Compounds | Major Method(s) of Testing | Dose. Conc | Main Effect | References |
|---|---|---|---|---|---|---|---|
|
| Twigs and leaves | Ethanol | Terpenoids | Induce lipopolysaccharide to produce inflammation in RAW 264.7 macrophage cells | 0.2–50.0 μM | 4 compounds—3α-hydroxyl-8,14,22Z,24-tetraenlanosta-26,23-olide; (5 | [ |
|
| Aerial parts | Chloroform, ethyl acetate, | Flavanoids | dimethylbenzene-induced ear oedema in mice | 200 mg/kg | AG ethyl acetate extract shows 18% inhibition against dimethylbenzene-induced ear edema in mice while carrageenin-induced paw edema in rats shows inhibition ratios 28.2% and 35.6%, after 2 and 6h, respectively. | [ |
| Carrageenin-induced paw oedema rat | 140 mg/kg | ||||||
|
| Leaves | Methanol/Petroleum ether extract | Flavanoids | Carrageenan-induced rat hind paw edema model in Albino mice | 400 mg/kg | Plant leaves extract possesses significant anti-inflammatory properties | [ |
|
| Leaves | Methanol | Flavanoids, tannins and saponins | Heat induced hemolytic method in human red blood cell (HRBC) membrane | 400 μg/kg | Leaves extract shows good antiinflammatory activity | [ |
|
| Stem bark | Methanol | Deodarin, quercetin, taxifolin | Carrageenin-induced paw edema in Albino rat | 100 mg/kg | Anti-inflammatory activity with 43.47% inhibition | [ |
|
| Leaves | Methanol | Cupressuflavone (CUF) | Carrageenan-induced paw edema model in Mice | 40, 80, and | CUF demonstrated antiinflammatory | [ |
|
| Berry | Alcohol/Water | Flavanoids (quercetin rutin, apigenin) chlorogenic acid | Acute-dextran and kaolin subacute inflammation induced in Wistar Rat | 10 mL/kg | The antiinflammatory action of the juniper extract, administered as a microemulsion in acute-dextran model was increased when compared to kaolin subacute inflammation induced model. | [ |
|
| Berry | Ethanol, n-butanol | Flavonoids (amentoflavone, cupressuflavone, hinokiflavone, and rutin) | Carrageenan-induced hind paw edema model in mice | 100 mg/kg | Ethanol extract of Joso berries displayed remarkable inflammatory inhibition ranging between 24.5% and 23.7% at 100 mg/kg in carrageenan-induced edema model | [ |
|
| Berry | Ethanol | Flavonoids (amentoflavone, cupressuflavone, hinokiflavone, and rutin) | carrageenan-induced hind paw edema model in mice | 100 mg/kg | JFB extract at a dose of 100 mg/kg. shows high antiinflammatory effect 26.9% | [ |
|
| Bark | Ethanol | Flavanoid, tannin | against albumin denaturation, HRBC membrane stabilization assay | 2500 μg/mL | [ | |
|
| Aerial parts | Methanol | Terpenoids | ear edema induced in mice | 3.2 mg/ear | [ | |
|
| Bark | Ethanol | Alkaloids, terpenoids, flavonoids | carrageenan-induced paw edema in Wistar Albino rat | 200 mg/kg | Percentage of inhibition is 44% at a dose of 200 mg/kg | [ |
|
| Heart wood | Ethanol | Taxoids, lignans | carrageenan-induced hind paw edema model inS wiss albino mice | 30–100 mg/kg | TBW shows significant antinociceptive and anti-inflammatory activities | [ |
|
| Bark | Methanol | Tasumatrol B, 1,13-diacetyl-10-deacetylbaccatin III (10-DAD) and 4-deacetylbaccatin III (4-DAB) | carrageenan-induced paw edema and Cotton-pellet oedema model in Wistar rats and Swiss albino mice | 20 and 40 mg/kg; 40 mg/kg | In a carrageenan-induced inflammation model, tasumatrol B at a dose of 20 mg/kg showed significant activity, while in a cotton-pellet edema model tasumatrol B was found to be highly significant at the dose of 40 mg/kg. | [ |
|
| Non-woody branches with leaves | Mother tincture (MT) | Polyphenols, flavonoids | Administered 2,4,6-trinitrobenzenesulfonic acid to induce intrarectal colitis in mice | 25 or 50 mg/kg | MT manage to relieve intestinal inflammation experimentally induce by TNBS in 7 days. | [ |
JFB—Juniper foetidissima berry; AG—Abies georgei; TBW—Taxus baccata heart wood.
In vivo and in vitro anticancer and cytotoxic studies of conifer extracts.
| Conifer spp. | Part Used | Nature of Extract | Compounds | In Vitro and in Vivo Model | Dose. Conc | Main Effects | References |
|---|---|---|---|---|---|---|---|
|
| Aerial parts | Chloroform, ethyl acetate, | Flavanoids | Human tumor cell lines-A549, QGY-7703, LOVO, 6T-CEM | 77.5, 11.1, 7.8, 32.8 μg/mL | AGC extract has potent tumour and antiproliferative effects in humor tumor cell lines | [ |
| (Mice) S180 tumours cell lines | 100, 200 and 400 mg/kg | AGC also exhibited activity in tumour growth inhibition in a dose-dependent manner, with ratios of 46.7, 53.1 and 31.0% at doses of 100, 200 and 400 mg/kg, respectively | |||||
|
| Female strobili | Water | Fatty acids and polyphenols | Laryngeal carcinoma HEp-2 cells | 100–500 μg/mL | AAE inhibit the activity of mitochondria complex I and induce redox stress and cytochrome c, which leads cleavage of nuclear proteins of larynx HEp-2 cancer cells | [ |
|
| Stem wood | Chloroform | Lignans (Matairesinol, dibenzylbutyrolactol, (−)-Wikstromol) | In vitro human cell lines (cervix, breast, colon, liver, CNS, prostrate) | In vitro cytotoxicity IC 50 value-Wikstromol (71.31–93.63) and Matairesinol (50.84–95.36) μg/mL | CD lignin mixture have potent to show a cytotoxic effect at the maximum in CNS and at the minimum in liver against cancer cell lines in a dose-dependent manner at 100 μg/mL from 49 to 95%. | [ |
| Human T lymphoblast, acute lymphoblastic leukemia cell line, Molt-4 and human promyelocytic leukemia cell line (HL-60) | IC50 (μg/mL) | AP9-cd-induced endogenous NO production leads to the generation of peroxide and disruption of mitochondrial membrane potential, leading to apoptotic pathway activation | [ | ||||
| In vivo swiss albino mice (K562 cells) | The lignin mixture displays anti-cancer effects by regulating annexin V binding, intracellular caspase activities and DNA fragmentation | ||||||
|
| Needle | Ethanol | Kaempferol, myricetin, isorhamnetin and quercetin | HepG2 cells | IC50 114.12 μg/mL | TFPNCD shows potent cytotoxicity by inhibiting the growth of HepG2 cells in a dose-dependent manner | [ |
|
| Leaves | Methanol | Flavonoids | Albino mice of Ehrlich Ascites Carcinoma (EAC). | 100–400 μg/gm | Tumor cell count as well as the amounts of ascetic tumour cells in packed cells were significantly reduced in infected mice treated with MC | [ |
|
| Berry | Methanol and water | Phenolic compounds | CaCo2 and HeLa carcinoma cell lines | IC50 1300–2500 μg/mL | Methanol and water extracts of JCB show potent antiproliferative activity against cancer cell lines | [ |
|
| Leaves | Chloroform | Polyphenols and lignan | human leukemia (HL-60) cells | 2.5 μg/mL | 7α-hydroxysandaracopimaric acid, a diterpenoid compound obtained from | [ |
|
| Aerial parts | Chloroform | Polyphenols | IC50 values (μg/mL) | It is found that JPCF disrupts cell cycle progression in the G0/G1phase and shows apoptotic, antiproliferative and necrotic effects on cancer cells lines | [ | |
| Human lung (A549) | 34.2 | ||||||
| Breast (MCF-7) | 24.5 | ||||||
| Liver (HepG2) cancer cells | 57.6 | ||||||
|
| Needle | Methanol | Quercetin, rutin | Rat brain tumor (C6) cell lines | IC50 values (μg/mL) | [ | |
|
| Leaf | Water | Polyphenols | PC12 cells | 25 μg/mL | [ | |
|
| Whole plant | DMSO | ND | Human keratinocyte HaCaT cell lines | 1–3 g/mL | PwM extracts inhibit the production of MCP-1 IL-6, IL-13 and but do not inhibit IL-8 production | [ |
|
| Woody twig | Ethanol | Phenolic compounds and flavonoids | Human hepatocarcinoma (HepG2) cell lines | IC50 (μg/mL) 52.0 | PK Extract exhibited a potent cytotoxic effect in the HepG2 cell line | [ |
|
| Branch | Ethanol | Phenolic compounds and flavonoids | Human leukemic U937 | IC50: 299 μg/mL | PK ethanol extract possesses anticancer activity against U937 human leukemic cells via apoptosis | [ |
|
| Leaves | Methanol | Phenolic compounds | MCF-7, A549, HT 1080 and HepG2 Huh-7 cancer cell lines | IC50 (μg/mL) | PM methanol extract possesses anticancer activity against human cancer cell lines | [ |
|
| Leaves, cones | Methanol | Phenolic compounds | HCT-116 human colon cancer and MDA-MB-231 human breast cancer cell lines | IC50 μg/mL | Methanol extracts of leaves had better activity on HCT-116 cells than seed cone extract, with IC50 values of 14.3 for 24 h and 4.59 for 72 h. Meanwhile, extracts did not show any significant cytotoxic effects on the cancer cell lines | [ |
|
| Heartwood | Methanol | Lignans 1 (taxiresinol 1) 2, 3 | colon, ovarian liver, and breast cancer cell lines | IC90 lignan 2 and 3 μg/mL | Taxiresinol 1 shows anticancer activity against ovary, colon, liver and breast cancer cell lines, while lignans 2 and 3 were found to be most active against Caco-2 cell lines | [ |
|
| All parts | ND | α-Conidendrin | MCF-7 andMDA-MB-231 cancer cell lines | 40 μM | α-conidendrin have the potential to inhibit human breast cancer cell lines MDA-MB-231 and MCF-7, showing viability of 73 and 82%, respectively | [ |
|
| Leaves | Water and ethanol | Phenolic compounds | A549 human lung cancer cell line | 111.2 and 112.7 μg/mL | PRL extract shows potent anticancer activity against cancer cell lines. | [ |
|
| Branches and leaves | Water | Polysaccharides | MCF7 | IC50 μg/mL | Purified polysaccharides (Pe4) on HeLa cells had the highest inhibitory effect, and its IC50 value is 89.9, while (Pe1) shows the best cytotoxic capacity against cancer lines HepG2 and MCF7, with IC50 conc. 132.0 and 169.0 μg/mL, respectively | [ |
| 169.0 | |||||||
| Hela | 89.9 | ||||||
| HepG2 | 132.0 | ||||||
|
| Leaves and non-woody branches | Mother tincture (MT) | Polyphenols including flavonoids | Caco-2 cells | 25 or 50 mg/kg | Caco-2 cells exposed to H2O2 and | [ |
|
| Leaves | Ethanol | ND | Human NSCLC (A549) cell lines | IC50 μg/mL | Extract of TO shows both anticancer and antiproliferative activities against NSCLC (A549) cell lines in a dose-dependent manner. | [ |
| 282 | |||||||
| Human normal embryonic cell lines (L-132) | 376 | ||||||
|
| ND | Mother tincture (MT) | Thujone | A375 human malignant melanoma cell line | 200 μg/mL | TRF as compared with TO MT on exposure to A375 cells exhibited highly cytotoxic, apoptotic and antiproliferative effects, but TRF shows a lower growth inhibitory response towards peripheral blood mononuclear cell (normal cells) | [ |
ND—Not determined; AGC—Abies georgei chloroform extract; AAE—Araucaria angustifolia water extract; TFPNCD—total flavonoids from the pine needles of Cedrus deodara; PRL—P. roxburghii leaves.
Conifers’ phytochemicals demonstrating neuroprotective potential in vitro and in vivo.
| Conifers spp. | Compounds with Neuroprotective Potential | Model | Effective Concentration | Relevant Bioactivities | Reference |
|---|---|---|---|---|---|
|
| Holophyllin-D | C6 glioma cells | 20 μM | Diterpenes compound holophyllin D shows neuroprotective potential in C6 glioma cells by inducing nerve growth factor | [ |
|
| Catechin, epicatechin and rutin | Rat | 10 mg/mL | AAE has antioxidant and neuroprotective properties as it decreases the TBARS levels, CAT activity and NO production in the hippocampus region of the brain in rats. | [ |
|
| Catechin, epicatechin, rutin, quercetin and apigenin | human dopaminergic SH-SY5Y cells | 5 μg/mL | Decrease in the production of neuron (ROS) and lipid peroxidation. | [ |
|
| Quercetin | cockroach | 200–400 μg/g | Neurotoxicity modulates the behavior of insects by altering the dopaminergic pathways, as quercetin has the ability to induce selective inhibitory actions on NMDA and GABA receptors and inhibit the enzyme acetylcholinesterase (AChE) | [ |
|
| Cedrin | PC12 cells | 0.1, 1 and 10 μM | PC12 cells injured by amyloid β1–42 can be improved by cedrin. Cedrin can reduce (ROS) overproduction, enhance the activity of SOD and decrease MDA content and inhibition of oxidative stress, improvement of mitochondrial dysfunction and suppression of apoptosis in PC12 cells | [ |
| Metasequoia glyptostroboides | Gallic acid, rutin, myricetin, kaempferol, quercitrin, epigallocatechin, epicatechin gallate epigallocatechin gallate and caffeic acid | Neuronal PC12 cells | 2 mg/mL | The extracts effectively reduced the hydrogen peroxide-induced lipid peroxidation in neuronal PC12 cells by decreasing intracellular ROS accumulation | [ |
|
| Catechin, quercetin dehydrate, astragalin and kaempferol | Mice | 50–100 mg/kg | Catechin displayed a potential effect protecting mouse brains from oxidative damage via the improvement of the antioxidant capacities of TAC, the GSH-redox system, SOD and CAT in the hippocampus region as well as the inactivation of cytokines such as NF-kB in pyramidal cells of the hippocampal CA1 region, while PNE shows antiamnesic properties and effects in Alzheimer’s, as it attenuated the increase in serum corticosterone level and up-regulation of GR hippocampal gene expression | [ |
|
| Needle extract | Mice | 50 mg/kg | Alkanes, sterols, terpenoids, and quercetin, which is found in | [ |
|
| Polyprenols | Mice | 25 mg/kg | Polyprenols significantly increased T-AOC, GSHPx, damaging peroxide components from cells in order to stop the lipid peroxidation chain reaction and avoid excessive hydrolysis to form NEP, MDA, SOD activity (remove free radicals) and β-site AβPP cleaving enzyme 1 (BACE1) expression, while NOS activity, MDA concentration, NO, concentration of Aβ1-42 and PS1 were reduced | [ |
|
| Pycnogenol (PYC) | Mice | 20 mg/kg | In the MPTP-induced mouse model, PYC could prevent dopaminergic neurons by reducing oxidative loads, suppressing glial cell activation, and inhibiting inflammatory responses | [ |
|
| Quercetin, rutin, gallic acid | Wistar albino | 100–300 mg/kg | Quercetin and gallic acid, both present in stem bark, have been shown to inhibit neuronal toxicity and apoptosis by reversing mitochondrial dysfunction and free radical development | [ |
|
| Water extract | Mice | 100 mg/kg | CNS depressant activity, anticonvulsant and muscle relaxant activity | [ |
|
| Arctigenin | Rat Cortical cells | 0.01 µM to 10.0 µM. | Arctigenin significantly attenuated glutamate-induced neurotoxicity by inhibiting the binding of [3H]-kainate to its receptors | [ |
|
| Polyphenols, flavonoids | Mice | 0–10 mg/mL | TS increased the level of total glutathiones | [ |
T-AOC—total antioxidative capacity; GSHPx—glutathione peroxidise; SOD—super oxide dismutase; NEP—neprilysin; MDA—malondialdehyde; NO—nitric oxide, NOS—nitric oxide synthase; PS1—presenilin 1, CAT—catalase.
Antidiabetic activity of different conifer extracts.
| Conifer spp. | Part Used | Compounds | Model | Induction of Diabetes | Dose. Conc | Effects | References |
|---|---|---|---|---|---|---|---|
|
| Seeds | Glucomannan | Albino wistar rats | Streptozotocin | 25 and 50 mg/kg |
Glucomannan reduce blood glucose level due to presence of D-glucosyl and β-1, 4-linked D-mannosyl units Decreases total cholesterol (TC) total glycerides (TG), high density lipoproteins cholesterol (HDL-C), very low-density lipoprotein cholesterol (VLDL-C) and low-density lipoprotein cholesterol (LDL-C) | [ |
|
| Heart wood | Flavonoids | Wistar albino rat | Alloxan | 500 mg/kg |
Reduction in blood sugar level from 49.79% within 21 days. | [ |
|
| Berry | Flavonoids | Wistar rat | Streptozotocin | 250 mg/kg |
JCB extract have potential to increase the peripheral glucose absorption and plasma insulin levels | [ |
|
| NR | NR | Rat | Streptozotocin-nicotinamide | 100–200 mg/kg |
Reduction in blood glucose levels Antihyperlipidemic activity in the form of the reduction in TG TC, LDL, and VLDL dose-dependently | [ |
|
| Leaves | Linolenic acid, oleic acid | Wistar-albino rats | Streptozotocin | 500 and 1000 mg/kg doses |
Leaf extracts rich in unsaturated fatty acids responsible for activating PPAR ϒ receptors or increasing the release of insulin from beta cells of the pancreas to reduce glucose levels | [ |
|
| Nut | Flavonoids | Rat | Alloxan | 250, 500, and 750 mg/kg |
Decrease the blood glucose level by inhibiting alpha-amylase enzyme activity Antihyperlipidemic | [ |
|
| Bark | Phenolic compounds | Rat | Glucose | 250, 500 mg/kg |
Stop enzymes (α-glucosidase and α-amylase) implicated in sugar metabolism antioxidant | [ |
|
| Bark | Phenolic compounds | NR | IC50 (µg/mL) at PB 70% and PB 50% |
PBEs ethanol extract at PB.70% and 50% shows higher α-amylase and β-glucosidases inhibitory activity, respectively | [ | |
| α-amylase | 254.2 | ||||||
| β-Glucosidase | 122.7 | ||||||
|
| Bark | Pynogenol | Human | NR | 100 mg |
Reduce blood glucose level in blood Elevated antioxidant defense mechanisms | [ |
|
| Bark | Quercetin | NR | Alpha amylase inhibitory activity | 100 μg/mL |
Quercetin present in extract displayed significant enzyme inhibitory activity against α-amylase, with 49.6% inhibition. | [ |
|
| Bark | Quercetin | Rat | Alloxan | 100, 300 and 500 mg/kg |
Anti-hyperglycemic activity of Antihyperlipidemic activity | [ |
|
| Branches and leaves | Water | Polysaccharides Pe4 (arabinose, galactose, glucose, xylose, mannose) | NR | 10–120 μg/mL |
Pe4 showing good type 2 antidiabetic activity by inhibiting α-glucosidase Inhibit human cervical cancer | [ |
NR—Not reported.
Conifer-derived commercially available products sold on the global market.
| Plant | Part Used | Trade Name | Phytochemicals Composition | Formulation | Dose/Duration | Product |
|---|---|---|---|---|---|---|
|
| Bark | Pycnogenol | Catechin, taxifolin, procyanidins, caffeic, p-hydroxybenzoic, ferulic, acids | Tablets, liquids, chewing gums, gels, ointments, capsules or lotions | 150 mg/day for 6 months |
|
|
| Bark | Oligopin | Caffeic acid, catechin, epicatechin, taxifolin and ferulic acid | Capsules | 150 mg for 10 days |
|
|
| Bark | Enzogenol | Flavanoids, proanthocyanidins | Tablets | 480–960 mg/day for 5–6 months |
|
|
| Needles | Ropren | Flavanoids | Tablets, capsules, lotions | 8.6 mg/kg for 28 days |
|
|
| Bark | Taxol | Paclitaxel | Injections | 30 mg/m2 every 3 weeks |
|
|
| Bark | Not found | Polyphenols, flavanoids, proanthocyanidins | Capsules | 1 capsule daily |
|